Other stocks that saw meaningful increases in the portfolio included Shopify (US:SHOP), UiPath, Pacific Biosciences of California (US:PACB) and 10x Genomics (US:TXG). The investment strategy was sound in an environment of falling cash rates and expanding valuations following on from the 2008 global financial crisis that rewarded her investors with consistent market outperformance. The vision came to a crashing end in 2022 when central banks globally began raising cash rates rapidly to cool inflation from spiralling out of control.